login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
CYCLERION THERAPEUTICS INC (CYCN) Stock News
USA
- NASDAQ:CYCN -
US23255M2044
-
Common Stock
1.87
USD
-0.05 (-2.6%)
Last: 10/31/2025, 8:00:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CYCN Latest News, Press Relases and Analysis
All
Press Releases
a month ago - By: Benzinga
- Mentions:
IVA
ABP
ONMD
VTVT
...
12 Health Care Stocks Moving In Monday's Pre-Market Session
a month ago - By: Benzinga
- Mentions:
ICU
ABOS
POAI
PSTV
...
12 Health Care Stocks Moving In Thursday's Intraday Session
a month ago - By: Stocktwits
Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today?
a month ago - By: Cyclerion Therapeutics, Inc.
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
a month ago - By: Cyclerion Therapeutics, Inc.
Cyclerion Announces Transformational Relaunch as a Neuropsychiatric Company
11 months ago - By: Cyclerion Therapeutics, Inc.
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
11 months ago - By: Cyclerion Therapeutics, Inc.
Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth
a year ago - By: Cyclerion Therapeutics, Inc.
Regina Graul, Ph.D., Promoted to Chief Executive Officer
a year ago - By: Cyclerion Therapeutics, Inc.
Regina Graul, Ph.D., Promoted to Chief Executive Officer
Please enable JavaScript to continue using this application.